Joseph Tochukwu Enebe1, Cyril Chukwudi Dim2, Emeka Francis Nnakenyi3, Hyginus Uzochukwu Ezegwui4, Benjamin Chukwuma Ozumba4. 1. Consultant, Department of Obstetrics and Gynaecology, Enugu State University of Technology Teaching Hospital , Parklane Enugu, Nigeria . 2. Senior Lecturer and Honorary Consultant, Department of Obstetrics and Gynaecology, College of Medicine, University of Nigeria , Enugu, Nigeria . 3. Lecturer and Honorary Consultant, Department of Morbid Anatomy, College of Medicine, University of Nigeria , Enugu, Nigeria . 4. Professor and Honorary Consultant, Department of Obstetrics and Gynaecology, College of Medicine, University of Nigeria , Enugu, Nigeria .
Abstract
INTRODUCTION: HIV-positive women are more likely to develop cervical neoplasm. HIV-positive women with low CD4 T-lymphocyte cell count may be more predisposed to cervical squamous intraepithelial lesions (SILs). This study aimed to determine the association between low cellular immunity of HIV positive women, and the prevalence and grade of cervical squamous intraepithelial lesions. MATERIALS AND METHODS: Pap smear was carried out on two cohorts of Highly Active Anti Retroviral Therapy (HAART) experienced HIV-positive women (178 per group) at the AIDS Prevention Initiative in Nigeria-Centre for Disease Control Adult Anti-Retroviral clinic of the University of Nigeria Teaching Hospital, Enugu, Nigeria from June to November, 2012. The study group had CD4 cell count of < 200 cells/μl while the control group had CD4 cell count of ≥200 cells/μl. RESULTS: The mean CD4 cell counts of participants in the study (low CD4) group was 127.9 ± 47.49 cells/ml while that of the control (high CD4) group was 489.2 ± 186.36 cells/ml (p < 0.001). The prevalence of SIL was 10.2% (18/176) for the low CD4 group, and 5.7% (10/176) for the high CD4 group [OR = 1.9 (95% CI: 0.85, 4.22)]. The commonest category of SILs identified was Low-grade Squamous Intraepithelial Lesion (LSIL), thus 11 (6.3%) in the study versus 7 (4.0%) in the control group (p = 0.703). CONCLUSION: Prevalence of cervical SILs among HIV positive women on HAART in Enugu, Nigeria is low and has no significant relationship with their CD4 cell count.
INTRODUCTION: HIV-positive women are more likely to develop cervical neoplasm. HIV-positive women with low CD4 T-lymphocyte cell count may be more predisposed to cervical squamous intraepithelial lesions (SILs). This study aimed to determine the association between low cellular immunity of HIV positive women, and the prevalence and grade of cervical squamous intraepithelial lesions. MATERIALS AND METHODS: Pap smear was carried out on two cohorts of Highly Active Anti Retroviral Therapy (HAART) experienced HIV-positive women (178 per group) at the AIDS Prevention Initiative in Nigeria-Centre for Disease Control Adult Anti-Retroviral clinic of the University of Nigeria Teaching Hospital, Enugu, Nigeria from June to November, 2012. The study group had CD4 cell count of < 200 cells/μl while the control group had CD4 cell count of ≥200 cells/μl. RESULTS: The mean CD4 cell counts of participants in the study (low CD4) group was 127.9 ± 47.49 cells/ml while that of the control (high CD4) group was 489.2 ± 186.36 cells/ml (p < 0.001). The prevalence of SIL was 10.2% (18/176) for the low CD4 group, and 5.7% (10/176) for the high CD4 group [OR = 1.9 (95% CI: 0.85, 4.22)]. The commonest category of SILs identified was Low-grade Squamous Intraepithelial Lesion (LSIL), thus 11 (6.3%) in the study versus 7 (4.0%) in the control group (p = 0.703). CONCLUSION: Prevalence of cervical SILs among HIV positive women on HAART in Enugu, Nigeria is low and has no significant relationship with their CD4 cell count.
Entities:
Keywords:
Cellular immunity; Cervical pre-malignant lesions; HIV sero-positivity
Authors: H Minkoff; L Ahdieh; L S Massad; K Anastos; D H Watts; S Melnick; L Muderspach; R Burk; J Palefsky Journal: AIDS Date: 2001-11-09 Impact factor: 4.177
Authors: K U Petry; D Scheffel; U Bode; T Gabrysiak; H Köchel; E Kupsch; M Glaubitz; S Niesert; H Kühnle; I Schedel Journal: Int J Cancer Date: 1994-06-15 Impact factor: 7.396
Authors: Cynthia Firnhaber; Daniel Westreich; Doreen Schulze; Sophie Williams; Maureen Siminya; Pam Michelow; Simon Levin; Mark Faesen; Jennifer S Smith Journal: J Int AIDS Soc Date: 2012-06-07 Impact factor: 5.396